MS and Family Planning: The Clinician’s Perspective

Volume 6, Issue 6

MS and Family Planning: The Clinician’s Perspective

In this issue:

Giving birth and raising a family. For many people with MS, the path to achieving those goals contains more questions than answers. Questions about timing — which should come first, pregnancy or disease stability on a DMT? Questions about genetics — can MS be passed on to the baby? Questions about fertility — is in vitro fertilization safe and effective, and how much does it increase disease activity? Questions their treating clinicians may not be able to answer with the most current research.

Join us as guest author Dr. Patricia Coyle from the Department of Neurology at the Renaissance School of Medicine at Stony Brook University in Stony Brook, New York, and Founder and Director of the Stony Brook Multiple Sclerosis Comprehensive Care Center provides the evidence-based answers to these and other questions in this issue of eMultipleSclerosis Review.

Learning objective:

Define the issues specific to people of childbearing age with MS, such as the safety of various DMTs and the influence of pregnancy on MS activity.

Author:

Patricia K. Coyle, MD, FAAN, FANA

Founder and Director, Stony Brook Multiple Sclerosis Comprehensive Care Center
Professor, Department of Neurology, Renaissance School of Medicine
Stony Brook University
Stony Brook, NY

Guest Faculty Disclosures

Dr. Coyle has indicated that she has received consulting fees from Accordant, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, EMD Serono, GlaxoSmithKline, GE Healthcare Bio-Science, Horizon Therapeutics, LabCorp, Mylan, Novartis AG, and Sanofi Genzyme. She has received grant/research support from Celgene, CorEvitas LLC, Genentech Roche, NINDS, and Sanofi Genzyme.

Unlabeled/Unapproved Uses

Dr. Coyle has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Program Directors:

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Guest Faculty Disclosures:

Unlabeled/Unapproved Uses:

Dr. Coyle has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: November 22, 2024
Expiration date: November 21, 2026

Start Issue